Safety and Efficacy of Melperone in the Treatment of Patients With Psychosis Associated With Parkinson's Disease.
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2014
At a glance
- Drugs Melperone (Primary)
- Indications Parkinson's disease; Psychotic disorders
- Focus Therapeutic Use
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual patient number (90) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Additional trial centres identified as reported by ClinicalTrials.gov.